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Introduction
Disease surveillance systems are an integral part of
any public health agency, and because of the
unpredictable nature of the virus, influenza
surveillance monitoring systems are particularly
essential. The influenza virus circulates in a fairly
predictable manner each year, typically from late fall
to early spring; however, throughout the duration of
any influenza season, influenza strains have the
ability to evolve through antigenic mutations, viral
reassortment, development of anti-viral resistance,
and alterations in virulence (Bautista et al., 2010).
Changes in the influenza strain may result in more
severe illness or death. Because of this, it is
especially important to closely monitor hospitalized
influenza patients, as they may be more likely to be
infected with the most virulent strains of influenza.
Influenza surveillance systems provide a picture of
influenza as it spreads throughout a community and,
most importantly, they are able to serve as warning
systems for public health officials. The objective of
this study was to describe the epidemiology of
severe-influenza associated hospitalizations and
deaths for the 2010-2011 influenza season in Clark
County, Nevada.

Abstract
Throughout the duration of any influenza season,
influenza strains have the ability to evolve through
mutation causing alterations in virulence. These
changes may result in severe illness or death among
susceptible populations; therefore, it is important to
closely monitor influenza-associated hospitalizations
and deaths. The University of Nevada, Las Vegas in
collaboration with the Southern Nevada Health
District analyzed data from the hospitalized influenza
morbidity and mortality surveillance project for Clark
County for the 2010-2011 influenza season. Among
the study population (N= 158): the influenza strain
type was found to be significantly associated with
deaths (n= 25), vaccination status was not found to be
significantly associated with death among
hospitalized patients, and transformed data showed
no statistically significant difference in the mean
length of hospital stay based on the influenza strain
type. These results will help inform public health
agencies of the impact of influenza-associated
hospitalizations and deaths, and inform the design of
future surveillance systems.
Key words influenza, morbidity, mortality,
hospitalized

National and state level surveillance programs are
useful in determining the health and economic burden
associated with influenza circulation and helping to
prepare for future pandemics (Thompson, Comanor,
& Shay, 2006). Surveillance systems are especially
critical in helping to determine estimates for vaccine
production, to anticipate antiviral medication use and
diagnostic testing needs, and to guide vaccination
programs in prioritizing immunization to those at the
greatest risk for morbidity and mortality (Thompson
et al., 2006). Surveillance measures help to assess the
burden of influenza on the health care system, which
tends to fluctuate seasonally, and depends upon
which influenza strain is predominantly circulating.
Decades of preceding trends of influenza-associated
hospitalizations and deaths have shown a pattern of
increased morbidity and mortality during seasons in
which influenza A (H3N2) viruses are the
predominantly circulating strains (Thompson et al.,
2010). Knowing this can help public health officials,
hospitals, and community agencies prepare for
increases in morbidity and mortality based solely on
the predicted circulating influenza strain.
Since the 2009 H1N1 pandemic, and with these
surveillance functions in mind, the Southern Nevada
Health District (SNHD), Office of Epidemiology
(OOE) has conducted a severe hospitalized influenza
morbidity and mortality surveillance program to
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describe the epidemiology of influenza in Clark
County, Nevada, which includes the city of Las
Vegas and the 38 million tourists that visit annually
(Las Vegas Convention and Visitors Authority
[LVCVA], 2011). The SNHD severe influenzaassociated hospitalizations and deaths surveillance
project most closely resembles the viral, morbidity,
and mortality surveillance components of the Centers
for Disease Control and Prevention (CDC) national
influenza surveillance program (CDC, 2010). In this
study, a secondary analysis was conducted of these
surveillance data to examine severe influenzaassociated hospitalizations and deaths, and to address
the following research questions. Among severe
influenza-associated hospitalizations: 1) Will the
strain of influenza be associated with death? 2) Will
vaccination status be associated with death? and 3)
Will there be a difference in the length of hospital
stay based on the influenza type?
Methods
Study Population and Inclusion Criteria
The study population consists of all residents of
Clark County, Nevada who were hospitalized for ≥
24 hours or expired between October 1, 2010 and
May 31, 2011, and met both the clinical case
definition and the laboratory criteria for diagnosis
described below.
Clinical case definition and laboratory criteria for
diagnosis:
1. Clinical case definition: Abrupt onset of at
least two of the following specific
symptoms: body aches, dry cough, fever,
headache, rhinitis, severe fatigue, and/or
sore throat. Other symptoms uncommon in
adults, but that might occur in children were
also included, such as: diarrhea, nausea,
otitis media, and vomiting; AND
2. Laboratory criteria for diagnosis:
Including one of the following:
a. Isolation of the virus by culture or
detection of virus by real time reverse
transcription polymerase chain reaction
(rRT-PCR) from nasopharyngeal or
throat swabs, nasal wash or nasal
aspirate(s);
b. Positive testing from a Food and Drug
Administration (FDA) approved rapid
diagnostic test. The rapid test is only
acceptable as a screening method within
the current influenza season if it has been
confirmed by rRT-PCR or culture;
however, it will be accepted as evidence
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of infection if the patient is hospitalized
or has expired.

The diagnostic testing methods differ based on the
identification method employed, the type of sample
from which evidence of influenza infection is
extracted, and the time required to process the results.
Rapid diagnostic testing methods detect antigens
specific to the influenza virus type (A or B) from any
of the following specimens (dependent upon the rapid
test utilized): nasopharyngeal swab/aspirate, nasal
wash/aspirate, lower nasal swab, throat swab, and/or
bronchioalveolar lavage (CDC, 2011b). The viral
subtype for influenza A viruses is unable to be
identified by rapid diagnostic testing. However, the
advantage to using rapid diagnostic testing is that
results are processed in 10 to 15 minutes (CDC,
2011b). There are multiple FDA approved rapid
diagnostic tests available; however, none are as
sensitive at detecting and/or isolating the virus as
viral culture or rRT-PCR.
Viral culture is considered to be the “gold standard”
for influenza virus testing, but can take from 2 to 14
days to isolate the virus from respiratory epithelial
cells (Ruest, Michaud, Deslandes, & Frost, 2003;
CDC, 2011b). To optimize effectiveness, initiation of
antiviral medication is recommended within 48 hours
of the onset of flu-like symptoms (CDC, 2011c);
therefore, the time period required for viral culture is
one disadvantage to its use. The rRT-PCR is another
diagnostic testing method more sensitive than the
rapid antigen test. The rRT-PCR requires
approximately 2-4 hours for the results to be
processed, which is considerably less than the viral
culture method. Both the viral culture and rRT-PCR
methods require specimen samples from any of the
following: nasopharyngeal swab/aspirate, nasal
swab/aspirate/wash, throat swab, bronchioalveolar
lavage, and bronchioalveolar lavage sputum (CDC,
2011b).
Exclusion Criteria
Subjects excluded from the surveillance project were
those not admitted for greater than 24 hours, did not
test positive for influenza by any of the diagnostic
testing methods listed, or whose primary residence
was located outside the SNHD jurisdiction (i.e.,
Clark County). Although cases among tourists are
reported by their home state for statistical purposes,
the SNHD is responsible for providing public health
services to tourists when they are visiting Clark
County.
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SNHD Data Collection Process
As part of routine public health practice, the SNHD
conducts seasonal influenza surveillance through
passive and active methods. Laboratory-confirmed
influenza is a reportable condition in Nevada; health
care providers (HCPs) and clinical laboratories must
report all cases to the designated health authority.
Passive surveillance also occurs in the review of the
cause of death (COD) listed on all death certificates
received by the SNHD. Any deaths attributed to
influenza are noted and actively investigated if
further information is required to assess the clinical
circumstances surrounding the death. Cases with
commonly listed complications of influenza illness as
the COD or as contributing factors were further
investigated to elicit influenza-related infection or
involvement.
The SNHD Disease Investigation and Intervention
Specialist staff members studied each report of
influenza to determine if it met the case definition for
severe-hospitalized influenza morbidity or mortality.
Compatible cases were investigated further according
to a standard protocol to collect demographic and
disease information.
Study Design and Approach
In this prospective cohort study, data were collected
upon receipt of laboratory-confirmation of influenza
infection and admission to the hospital for greater
than 24 hours. Patients were followed forward in time
until either one of two outcomes occurred: discharge
or death. A descriptive approach was utilized to
depict the distribution of severe influenza-associated
hospitalizations and deaths, and an analytical
approach was utilized to identify associations
between the various predictor variables of interest
(i.e., age, gender, race, ethnicity, ICU status,
mechanical ventilation status, underlying conditions,
antiviral medications, and vaccination status) and
death among the study population.
Data Analysis
The variables collected were operationalized and the
following statistical methods and software were
employed: Chi-Square and ANOVA statistical
methods, Microsoft® Excel, and PASW, SPSS®
software versions 18 and 19. Population-based
hospitalization and mortality rates were calculated
using the 2010 U.S. Census Bureau statistics for
Clark County, Nevada (US Census Bureau, 2011).
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Human Subjects
Institutional Review Board (IRB) approval was
obtained for this research study from the UNLV IRB.
The data collection process was completed by the
SNHD in accordance with mandates set forth by the
Nevada Administrative Code for the purposes of
routine public health practice. The data were deidentified of all personal patient identifiers, and
permission was obtained from the SNHD to analyze
this information for the purposes of this project.
Results
Population characteristics
One hundred and fifty-eight (N= 158) severe
influenza-associated hospitalizations and deaths were
reported to the SNHD for Clark County, Nevada
during the study period. The first reported case
occurred in the week ending October 2, 2010 (CDC
week 39), and the last occurred in the week ending
May 7, 2011 (week 17); the peak number of cases
was reported in the week ending February 19, 2011
(week 7) (Figure 1). Males accounted for 81 cases
(51.3%); females accounted for 77 cases (48.7%).
Race was obtained from the hospital medical records
demographic face sheet, and subjects were
categorized as follows: 9 Asian/Pacific Islander
(5.7%), 27 black (17.1%), 2 Native American or
Alaskan Native (1.3%), 81 white (51.3%), and 39
other (24.7%). Approximately 71% of the study
population was non-Hispanic (n= 112). Age of
subjects ranged from newborn to over ninety years of
age.
Mortality and hospitalization rates
During the study period, a total of 25 severeinfluenza associated deaths were reported to the
SNHD. The overall severe influenza-associated
mortality rate for Clark County based on the 2010
census data (total population 1,951,269 residents in
Clark County) was 1.28 per 100,000 (US Census
Bureau, 2011). Severe influenza-associated
hospitalizations and deaths were further categorized
by age group, and by mortality and hospitalization
rates by age group (Table 1). Females accounted for
68% of deaths, even though the overall study
population was normally distributed with regards to
gender. A relative risk was calculated to determine if
females were more likely to die than males, but these
findings were not found to be statistically significant,
RR= 2.235 (C.I. 0.972, 5.423), p= 0.059.
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Figure 1. Number of cases by ending date of week of hospital admission by strain type- Clark County, 2010-2011
influenza season.
Table 1. Severe influenza-associated hospitalizations and deaths by age group- Clark County, 2010-2011 influenza
season.
Age groups
(years)
Totals
(N= 158)

All deaths by
age group *
n= 25 (%)

Mortality rate
per 100,000
1.28

Hospitalizations
by age group †
n= 153 (%)

Hospitalization
rate per 100,000
6.82

<5

2 (8)

1.44

39 (25.5)

28.07

5 – 49

7 (28)

0.56

49 (32.0)

3.92

50-59

5 (20)

2.09

20 (13.1)

8.37

60-69

6 (24)

3.31

16 (10.5)

8.82

70-79

2 (8)

2.09

19 (12.4)

19.82

≥ 80

3 (12)

6.51

10 (6.5)

21.72

Females

17 (68)

Gender
NA

74 (48.4)

NA

Males

8 (32)

NA

79 (51.6)

NA

*Includes both the deaths admitted to the hospital (n= 20) and those who were not (n= 5).
†Includes deaths that were admitted to the hospital (n= 20).
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To compare the 2010-2011 severe influenza
morbidity and mortality rates to the national rates, the
data were recalculated to reflect the same time period
from October 1, 2010 through April 30, 2011 and to
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reflect the same age group categories utilized by the
CDC (Table 2). Overall, the hospitalization rates in
Clark County are significantly lower than those of the
nation.

Table 2. Comparison of Clark County and U.S. national influenza-associated hospitalization rates from October 1,
2010 through April 30, 2011.

Age group
0-4 years

Clark County, Nevada (n= 153)*
Hospitalization rate per 100,000
28.1 (n= 39)

United States†
Hospitalization rate per 100,000
43.8

5- 17 years

2.6 (n= 9)

8.5

18-49 years

4.4 (n= 40)

10.7

50-64 years

8.5 (n= 29)

21.7

≥ 65 years

16.3 (n= 36)

62.5

*Includes deaths that were admitted to the hospital (n= 20).
†FluSurv-NET surveillance data for the 2010-2011 influenza season (CDC, 2011a).
According to the CDC (2011a), there were 311
laboratory-confirmed deaths due to pneumonia and
influenza in the U.S. during the 2010-2011 influenza
season (October 3, 2010 through May 21, 2011). Of
these deaths, 105 deaths were among children less
than 18 years of age (CDC, 2011a). In Clark County,
of the 25 reported deaths, there were 3 deaths under
the age of 18 for this same time period. These rates
were comparable to the national numbers, but due to
the small sample size we are unable to make any
further inferences regarding influenza-related
pediatric deaths in Clark County.
Influenza vaccination status
Vaccination status was obtained on 132 of the 158
subjects (83.5%). Individuals who received the
influenza vaccine prior to 2010, during, or after their
hospitalization were categorized as not having
received the 2010-2011 influenza vaccine for the
purposes of this study. Of the total study population
(N= 158), 93 (58.9%) subjects were not vaccinated,
39 subjects were (24.7%), and 26 subjects were
classified as unknown (16.5%). Among the nonvaccinated, 8 patients expired (8.6%), and among the
vaccinated, 3 patients expired (7.7%); the remaining
deaths (n= 14) had an unknown vaccination status.
Chi-square analysis was run between vaccination
status and death (excluding those that were classified
as unknown), and vaccination status was not found to
be significantly associated with death among
hospitalized patients, χ² (1, n= 132) = 0.030, p=
0.584. Fisher’s Exact Test p-value was reported due

to the small sample size. Relative risk was calculated
and also found to be non-significant, RR= 0.894 (C.I.
0.192, 3.481)
Influenza strain type
The largest proportion of test results were reported as
influenza rapid tests (n= 86, 54.4%), followed by
real-time reverse transcriptase polymerase chain
reaction (rRT-PCR) (n= 67, 42.4%), both rapid test
and rRT-PCR (n= 4, 2.5%), and viral culture (n= 1,
0.6%). The majority of testing occurred in the
hospital laboratory setting (n= 91, 57.6%), and the
remaining were performed either through commercial
laboratories (n= 58, 36.7%), out-of-state laboratories
(n= 8, 5.1%), or the Southern Nevada Public Health
Laboratory (n= 1, 0.6%). Influenza A (no subtype)
was the most commonly reported strain among severe
influenza-associated hospitalizations and deaths (n=
94, 59.4%), followed by influenza A (H1N1) (n= 36,
22.8%), influenza B (n= 27, 17.1%), and influenza A
(H3) (n= 1, 0.6%).
Influenza strain was significantly associated with
deaths, G= 16.2, p= 0.001. Of the 36 cases diagnosed
with influenza A (H1N1), 11 (30.6%) resulted in
death. Patients diagnosed with influenza B (n= 27)
demonstrated a similar proportion of deaths at 29.6%
(n= 8). Influenza A (no subtype) was the most
commonly diagnosed influenza strain (n= 94) in
Clark County; however, it had the lowest proportion
of deaths at 6.4% with 6 deaths occurring among
those who tested laboratory positive.
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The distribution of influenza strain by the ending date
of the week of admission, or death in the case of
those who expired at home (n= 5), is displayed in
Figure 1. Results show the week ending on February
19, 2011 (week 7) to be the peak of influenzaassociated hospitalizations and deaths in Clark
County with 26 cases reported. According to the
CDC summary of the 2010-2011 influenza season,
national influenza activity peaked in early February
as well (CDC, 2011a).
Length of stay
Length of hospital stay ranged from 1 to 59 days. The
length of stay distribution for influenza-associated
hospitalizations and deaths (n= 153) was non-normal
(Shapiro-Wilks= 0.645, df 152, p< 0.0001),
leptokurtic (kurtosis= 9.951), and skewed to the right
(skewness= 2.897) because the majority of patients
(70.4%) were admitted for ≤ 7 days and due to the
influence of extreme outliers (Table 3). The mean
length of stay was 7.70 days (95% C.I. 6.11, 9.30),
SD= 9.943. The median and mode were calculated by
influenza strain type and compared to the mean prior
to log transformation (Table 3).
Subjects who expired outside of the hospital setting
(length of stay= 0 days) and the sole patient with
laboratory-confirmed influenza A (H3N2) were
excluded (n= 152) from further analyses. The nonparametric equivalent of an ANOVA (KruskalWallis) was employed to investigate whether there
was a statistically significant difference in the median
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length of stay based on influenza strain type using a
rank test. These results were found to be nonsignificant, p= 0.347. The length of stay data were
log transformed to achieve a more normal
distribution (skewness= 0.444, kurtosis= -0.390);
afterward, all values in the data set fell within 3
standard deviations of the mean (M= 1.500, SD=
1.00). After transformation, an ANOVA was run
between the log-transformed length of stay data and
the influenza strain type. These results were also
found to be non-significant, F= 0.893, p= 0.412,
indicating that there was no statistically significant
difference in the mean length of stay based on
influenza strain type.
An analysis of covariance (ANCOVA) was utilized
to control for other factors that may influence the
relationship between length of stay and influenza
strain type. The following variables were evaluated:
age, gender, race, ethnicity, ICU status, mechanical
ventilation status, underlying conditions, antiviral
medications, and vaccination status. The following
factors were statistically significant in the final
adjusted model: ICU status (p= 0.010), mechanical
ventilation (p= 0.033), and underlying conditions (p=
0.022). Further analyses of the underlying conditions
were not performed due to inadequate sample sizes.

Table 3. Length of hospital stay by influenza strain type (mean, median, and mode prior to log transformation)Clark County, 2010-2011 influenza season.
Influenza B

Minimum

(n=24)
1

Influenza A
(no subtype)
(n=94)
1

Influenza A
(H1N1)
(n=34)
1

Influenza A
(H3)
(n=1)
1

(n=153)
1

Maximum

22

59

34

1

59

Median

4

4

5.50

1

4

Mode

2

2

2

1

2

Mean

5.46

7.96

8.59

1

7.70

Standard Deviation

4.836

11.273

8.560

NA

9.943

Length of stay (days)

Discussion
This research study describes the epidemiology of
severe influenza-associated hospitalizations and

Total

deaths in Clark County, Nevada, for the 2010-2011
influenza season. Results showed that the number of
deaths identified in this study were lower in
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comparison to what is expected according to national
numbers reported by a subset of states to the CDC. In
comparison to males, a disproportionate number of
females (68%) died as a result of severe influenzaassociated complications. Factors that may have
contributed to this include small sample size and an
undetermined combination of underlying conditions
or co-morbidities among females in the study
population. The greatest proportion of deaths
occurred in the 5-49 age group (n= 7), and the lowest
proportion of deaths occurred in the < 5 years and the
70-79 years age groups (n= 2, for both). The small
sample size may account for the fact that more deaths
were not observed among the older age groups (≥ 65
years), as would be expected according to national
and historic trends (Thompson et al., 2010).
The data showed a statistically significant difference
among severe influenza-associated deaths by strain
type. The proportion of deaths (n= 8) among patients
diagnosed with influenza B was 29.6%, which was
similar to the proportion of deaths (n= 11) among
patients diagnosed with influenza A (H1N1) at
30.6%. In comparison, the proportion of deaths
among patients diagnosed with influenza A (no
subtype) was much less at 6.4%.
However, our study is limited by the laboratory
testing ordered and performed on the study
population. The majority of these tests were rapid
antigen results; which are only able to differentiate
between influenza A and influenza B viruses (CDC,
2011b). Therefore, an unknown proportion of
influenza A isolates (no subtype) could be any
undetermined influenza A subtype. Not being able to
differentiate between the influenza A subtypes is a
significant limitation to our study because there are
differences in virulence between the influenza A
virus subtypes. Historically, this is supported by
higher rates of hospitalizations and deaths during
influenza seasons in which influenza (H3) viruses
predominate (Thompson et al., 2010). Influenza rapid
tests range in sensitivity from 50% to 70% and range
in specificity from 90% to 95%; this translates to
considerable variation in the positive and negative
predictive values of the tests as the prevalence of
disease fluctuates throughout the season (CDC,
2011b). Because of these concerns, it is difficult to
report the analysis of the influenza A (no subtype)
data with external validity.
Comparison of vaccination status with death among
the study population demonstrated that there was no
statistically significant association between
vaccination status and death. These results should be
interpreted cautiously due to the small sample size
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and the fact that vaccination status was only obtained
on 11 of the 25 deaths, which renders these results
inconclusive. The vaccination status classification
“unknown” includes subjects who were unable to be
confirmed through any of the methods described
below.
Vaccination status was the most difficult variable to
collect because people have multiple sources
throughout their community from which to obtain
influenza vaccination. The SNHD registers patient
vaccination information with the online statewide
Nevada vaccination registry: WebIZ. However, there
is not one central source for immunization records,
which made it difficult to find the vaccination status
of people who received their influenza vaccination
from sources other than the SNHD. Vaccination
status was also limited by recall bias and death,
further making it difficult to confirm. If the
vaccination history was unknown, attempts were
made to obtain vaccination records from multiple
sources including hospital and provider patient
records, and immunization registries.
Lastly, the type of influenza vaccine (inactivated or
live attenuated) administered was also not
differentiated. It is difficult to ascertain if or how
these omissions may have affected the analysis, but it
may be a confounding factor in any associations
between vaccination status and influenza-associated
hospitalizations. In the future, more detailed data
collection in regards to the vaccination status may
resolve these limitations.
There was no statistically significant difference in the
mean length of stay based on the influenza strain
type. This could be due to i) a relatively small sample
size and unequal sample sizes once the study
population was divided further by influenza strain
types, and ii) lack of data reflecting the further
characterization of the patients with laboratoryconfirmed influenza A (no subtype). As a result, we
do not know what proportions of these patients were
infected with influenza A (H3) or (H1) viruses, or
possibly an unknown influenza A subtype. In
addition, we do not have detailed data regarding
underlying conditions with which to draw further
conclusions (e.g., the presence of multiple underlying
conditions, or what “other” conditions may include).
There are many logistical factors that could extend
the length of hospital stay (e.g., availability of
outpatient beds), many of which were unable to be
accounted for in this study.
In the ANCOVA analysis, several factors were
analyzed and only ICU status, placement on
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mechanical ventilation, and underlying conditions
were statistically significant. The fact that admission
to the ICU and placement on a mechanical ventilator
extend length of stay was an expected finding, as
both of these variables indicate a higher acuity of
illness. Further analyses of the underlying conditions
were unable to be performed due to inadequate
sample sizes.
Multiple underlying conditions and co-morbidities
were not analyzed in this study. If the patient did not
have one of the conditions listed on the survey, a
review of their medications was performed to
determine if a medical condition existed that was not
listed as an admitting diagnosis. Patients with
multiple underlying conditions and co-morbidities
were limited to the classification of just one. It is
known that specific underlying conditions (e.g.,
asthma) and co-morbidities (e.g., COPD) can be
exacerbated by influenza infection. Chronic health
conditions can commonly occur in association with
each other (e.g., diabetes and heart disease often
occur in conjunction with one another), and this
information would have been helpful in determining
which combination of diseases contributed to severe
influenza-associated deaths among our study
population. Future surveillance projects should
attempt to obtain this information in order to be able
to further analyze these relationships.
There are several limitations to consider when
interpreting the findings from this secondary analysis
of the 2010-2011 severe influenza-associated
hospitalizations and deaths surveillance data
collected by the SNHD. Foremost, it should be noted
that the purpose of this project was for surveillance.
The data collected are representative of routine public
health practice and the data collection process is
reflective of this; therefore, the analysis of these
results is considered to be secondary and is subject to
the limitations specific to secondary analyses.
While our sample size for this study was small (N=
158), the information gathered is still beneficial for
future comparisons of severe influenza-associated
hospitalizations and deaths surveillance data
conducted in Clark County. It is expected that data
obtained from the 2010-2011 severe influenzaassociated hospitalizations and deaths surveillance
project will help guide subsequent projects and will
provide an important database of information from
which to compare future trends in the epidemiology
of influenza specific to Clark County, Nevada.
Surveillance systems are vital to public health efforts
to protect the population; and influenza surveillance
is especially vital because the virus is capable of
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changing its viral composition within a single flu
season.
Current national surveillance systems are only
capable of capturing a limited picture of influenza
activity each season. It is vital for smaller public
health agencies, such as the SNHD, to conduct
surveillance on severe-influenza hospitalizations and
deaths. The SNHD is responsible for the public
health of approximately 1.95 million people, roughly
72% of Nevada’s population, as well as the estimated
38 million people who visit Las Vegas as a popular
tourism destination each year (LVCVA, 2011; US
Census Bureau, 2011). To protect the population of
any city, this requires surveillance of circulating
strains, monitoring the population closely for unusual
influenza activity, and monitoring severe influenzaassociated hospitalizations and deaths for potential
changes in virulence. Changes in the influenza virus
would most likely result in hospitalization or death,
and because of this, projects such as this one are
essential to monitoring, maintaining, and improving
public health.
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